AZN - Why Heat Biologics Inovio Pharmaceuticals and Novavax Are Getting Clobbered Today
Shares of the COVID-19 vaccine players Heat Biologics (NASDAQ: HTBX), Inovio Pharmaceuticals (NASDAQ: INO), and Novavax (NASDAQ: NVAX) are all starting the week off on a sour note. Heat Biologics' stock is down by 13%, Inovio's shares are under water by 10.6%, and Novavax's equity is in the red by 11.1% as of 10:09 a.m EDT Monday morning.
What's spooking investors? Reports surfaced over the weekend that President Donald Trump may green-light AstraZeneca's (NYSE: AZN) experimental COVID-19 vaccine by October. The approval, if it happens, would likely occur through a mechanism known as an emergency use authorization (EUA).
Image source: Getty Images.